Tecon Biology Co Ltd
SZSE:002100
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
5.71
8.94
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Tecon Biology Co Ltd
Cost of Revenue
Tecon Biology Co Ltd
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
T
|
Tecon Biology Co Ltd
SZSE:002100
|
Cost of Revenue
-¥15.9B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-24%
|
CAGR 10-Years
-17%
|
|
|
Tongwei Co Ltd
SSE:600438
|
Cost of Revenue
-¥94.7B
|
CAGR 3-Years
-32%
|
CAGR 5-Years
-31%
|
CAGR 10-Years
-21%
|
|
|
H
|
Heilongjiang Agriculture Co Ltd
SSE:600598
|
Cost of Revenue
-¥3.6B
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-51%
|
CAGR 10-Years
2%
|
|
|
B
|
Beijing Dabeinong Technology Group Co Ltd
SZSE:002385
|
Cost of Revenue
-¥25.9B
|
CAGR 3-Years
1%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-6%
|
|
|
New Hope Liuhe Co Ltd
SZSE:000876
|
Cost of Revenue
-¥118.3B
|
CAGR 3-Years
0%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-6%
|
|
|
Jiangxi Zhengbang Technology Co Ltd
SZSE:002157
|
Cost of Revenue
-¥6.2B
|
CAGR 3-Years
50%
|
CAGR 5-Years
20%
|
CAGR 10-Years
9%
|
|
Tecon Biology Co Ltd
Glance View
Tecon Biology Co., Ltd. engages in the production and sale of animal vaccines, feed, and vegetable protein feed. The company is headquartered in Urumqi, Xinjiang and currently employs 5,669 full-time employees. The company went IPO on 2006-12-26. The firm's main businesses and products include premium incomes, slaughter processing and distribution of meat products, pig farming, production and distribution of feeds and veterinary drugs, and agricultural products processing. The firm mainly operates its businesses within domestic markets, with Xinjiang Province as its main market.
See Also
What is Tecon Biology Co Ltd's Cost of Revenue?
Cost of Revenue
-15.9B
CNY
Based on the financial report for Sep 30, 2024, Tecon Biology Co Ltd's Cost of Revenue amounts to -15.9B CNY.
What is Tecon Biology Co Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-17%
Over the last year, the Cost of Revenue growth was 9%. The average annual Cost of Revenue growth rates for Tecon Biology Co Ltd have been -7% over the past three years , -24% over the past five years , and -17% over the past ten years .
You don't have any saved screeners yet
